These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3445175)

  • 21. [Clinical evaluation of the drug abdoman in peptic ulcer].
    Riabova MV; Kurbatskaia IuS
    Sov Med; 1973 Aug; 36(8):140-1. PubMed ID: 4149627
    [No Abstract]   [Full Text] [Related]  

  • 22. [Retrospective study of the evaluation of peptic ulcer recurrence after 4 weeks of pirenzepin (Gastrozepin) treatment].
    Krempler F; Sandhofer F; Kalk A
    Wien Med Wochenschr; 1983 Nov; 133(21):553-7. PubMed ID: 6689235
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Remote results of the preventive treatment of peptic ulcer].
    Samson EI; Kushnir LD
    Vrach Delo; 1988 Feb; (2):82-4. PubMed ID: 3381531
    [No Abstract]   [Full Text] [Related]  

  • 24. [Treatment of peptic ulcer with the anabolic steroid retabolit].
    Gandziev KhE; Mizamudinov ShM
    Vrach Delo; 1974 Mar; (3):76-9. PubMed ID: 4468673
    [No Abstract]   [Full Text] [Related]  

  • 25. Evaluation of a new bismuth-free triple therapy in nude mice and humans.
    Karita M; Tsuda M; Okita K; Sugiyama T; Nakazawa T
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S31-4. PubMed ID: 8574732
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A granulocyte concentrate in the combined treatment of peptic ulcer patients].
    Preobrazhenskiĭ VN; Kirillov VA; Kostiurina LM; Katkov VI
    Vrach Delo; 1986 Oct; (10):61-5. PubMed ID: 3798890
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of Helicobacter pylori eradication and antisecretory maintenance therapy on peptic ulcer recurrence in cirrhotic patients: a prospective, cohort 2-year follow-up study.
    Tzathas C; Triantafyllou K; Mallas E; Triantafyllou G; Ladas SD
    J Clin Gastroenterol; 2008 Jul; 42(6):744-9. PubMed ID: 18277886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Follow-up on 242 patients with peptic ulcer disease one year after eradication of Helicobacter pylori infection.
    Berstad A; Hatlebakk JG; Wilhelmsen I; Berstad K; Bang CJ; Nysaeter G; Hausken T; Weberg R; Nesje LB; Hjartholm AS
    Hepatogastroenterology; 1995; 42(5):655-9. PubMed ID: 8751230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Some aspects of the critical evaluation of peptic ulcer therapy in patients.
    Mózsik G; Bertelli A; Deak G; Nagy L; Patty I; Simon L; Tárnok F; Jávor T
    Int J Clin Pharmacol Res; 1985; 5(6):447-55. PubMed ID: 4093220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Highly significant change of the clinical course of relapsing and complicated peptic ulcer disease after cure of Helicobacter pylori infection.
    Labenz J; Börsch G
    Am J Gastroenterol; 1994 Oct; 89(10):1785-8. PubMed ID: 7942667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
    Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
    Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Urogastrone in the treatment of peptic ulcer: yes or no?].
    Stasiewicz J; Janke A; Moniuszko-Jakoniuk J
    Pol Tyg Lek; 1986 Dec 22-29; 41(51-52):1646-9. PubMed ID: 3495791
    [No Abstract]   [Full Text] [Related]  

  • 34. THE ROLE OF CALCIUM-REGULATING SYSTEM IN THE PATHOGENESIS AND SANOGENESIS OF PEPTIC ULCER DISEASE AND POSSIBILITY OF ITS CHANGES CORRECTION IN THE TREATMENT OF RECURRENT DISEASE.
    Fomina LA
    Eksp Klin Gastroenterol; 2016; (10):19-24. PubMed ID: 29889366
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Riboxin treatment of peptic ulcer patients].
    Dorofeev GI; Sonina SI; Luft VM; Lisochkin BG; Marina AP
    Vrach Delo; 1984 Feb; (2):86-8. PubMed ID: 6719882
    [No Abstract]   [Full Text] [Related]  

  • 36. Helicobacter pylori eradication with bismuth subnitrate, oxytetracycline and metronidazole in patients with peptic ulcer disease.
    Wilhelmsen I; Weberg R; Berstad K; Hausken T; Hundal O; Berstad A
    Hepatogastroenterology; 1994 Feb; 41(1):43-7. PubMed ID: 8175114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Tripotassium-dicitrato bismuthate in the treatment of peptic ulcer and the prevention of its recurrence].
    Gibiński K; Nowak A; Marlicz K; Depczyńska A; Dzieniszewski J; Milewski B; Gabryelewicz A; Kosidło S
    Pol Tyg Lek; 1984 Nov; 39(47):1547-50. PubMed ID: 6393096
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinico-experimental study on the use of sulglycotide in the treatment of peptic ulcer].
    De Ciutiis D; Verrengia L; Sagliocco M; Guadagnino V; Carchietti E
    Minerva Gastroenterol; 1976; 22(4):323-8. PubMed ID: 798131
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of ulcer disease with temechine].
    Nogaller AM; Khan VG
    Klin Med (Mosk); 1975 Oct; 53(10):52-6. PubMed ID: 7709
    [No Abstract]   [Full Text] [Related]  

  • 40. [Comparative evaluation of the therapeutic effect of oxyferriscorbone in peptic ulcer].
    Spivak AM; Reĭngardt VK; Galetskaia TM; Liashko NA; Litinskaia EV
    Vrach Delo; 1985 Aug; (8):56-9. PubMed ID: 4072113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.